Xlear, a health products company, was sued by the FTC for falsely marketing its saline nasal spray as a preventative measure against COVID-19. The FTC claimed Xlear's advertisements misrepresented scientific studies and made unsupported health claims. Although the Trump administration sought to dismiss the case, Xlear aims to challenge the FTC’s authority over health claims in court. This situation unfolds amid a climate of shifting government policies and controversies regarding public health messaging.
In a bid to protect against Covid-19, Xlear marketed its nasal spray, claiming its ingredients could block viruses, leading to a lawsuit for unsupported health claims.
Xlear wishes for its day in court even after the Trump administration dismissed the FTC's lawsuit that criticized its misleading health claims regarding a nasal spray.
Collection
[
|
...
]